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A Unified Model for Differential Expression
Analysis of RNA-seq Data via L1-Penalized
Linear Regression
Kefei Liu, Jieping Ye, Senior Member, IEEE, Yang Yang, Li Shen, Member, IEEE, and Hui Jiang
Abstract—The RNA-sequencing (RNA-seq) is becoming increasingly popular for quantifying gene expression levels. Since the
RNA-seq measurements are relative in nature, between-sample normalization of counts is an essential step in differential expression
(DE) analysis. The normalization of existing DE detection algorithms is ad hoc and performed once for all prior to DE detection, which
may be suboptimal since ideally normalization should be based on non-DE genes only and thus coupled with DE detection. We
propose a unified statistical model for joint normalization and DE detection of log-transformed RNA-seq data. Sample-specific
normalization factors are modeled as unknown parameters in the gene-wise linear models and jointly estimated with the regression
coefficients. By imposing sparsity-inducing L1 penalty (or mixed L1/L2-norm for multiple treatment conditions) on the regression
coefficients, we formulate the problem as a penalized least-squares regression problem and apply the augmented lagrangian method
to solve it. Simulation studies show that the proposed model and algorithms outperform existing methods in terms of detection power
and false-positive rate when more than half of the genes are differentially expressed and/or when the up- and down-regulated genes
among DE genes are unbalanced in amount.
Index Terms—RNA-seq, normalization, differential analysis, augmented Lagrangian method, L1-penalized regression
✦
1 INTRODUCTION
Ultra high-throughput sequencing of transcriptomes
(RNA-seq) is a widely used method for quantifying gene
expression levels due to its low cost, high accuracy and
wide dynamic range for detection [1]. As of today, modern
ultra high-throughput sequencing platforms can generate
hundreds of millions of sequencing reads from each bi-
ological sample in a single day. RNA-seq also facilitates
the detection of novel transcripts [2] and the quantification
of transcripts on isoform level [3], [4]. For these reasons,
RNA-seq has become the method of choice for assaying
transcriptomes [5].
One major limitation of RNA-seq is that it only pro-
vides relative measurements of transcript abundances due
to difference in library size (i.e., sequencing depth) between
samples [6]. Normalization of RNA-seq read counts is re-
quired in gene differential expression analysis to correct
for such variation between samples. A popular form of
between-sample normalization is achieved by scaling raw
read counts in each sample by a sample-specific factor
related to library size [6], [7]. This include CPM/RPM
(counts/reads per million) [8], quantile normalization [9],
[10], upper-quartile normalization [11], trimmed mean of M
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values [8] and DESeq normalization [12]. Also, commonly-
used gene expression measures, e.g., TPM (transcript per
million) [13], and RPKM/FPKM (reads/fragments per kilo-
base of exon per million mapped reads) [1], [2], also correct
for difference in gene length within a sample [14] (the
so-called within-sample normalization). In particular, the
CPM/RPM (counts/reads per million) [8], TPM (transcript
per million) [13], and RPKM/FPKM (reads/fragments per
kilobase of exon per million mapped reads) [1], [2] for the
i-th gene from the j-th sample are respectively defined as
cpmij = 10
6 cij
Nj
fpkmij = 10
9 cij
li⋅Nj
tpmij = 10
6 cij/li
∑
i
cij/li
(1)
where cij is the observed read count for gene i from the
j-th sample, Nj = ∑
i
cij is the sequencing depth in the j-th
sample, and li be the length of gene i. In this work we focus
on between-sample normalization.
In traditional count-based RNA-seq analysis methods,
the read counts for each gene are assumed to follow a
Poisson [15] or negative binomial (NB) distribution. One
issue with the count-based RNA-seq analysis methods is
that their procedures are complicated and contain many ad
hoc heuristics. Moreover, the Poisson or NB distributions
of counts are mathematically less tractable than the normal
distribution [16], [17]. This makes count-based methods
difficult to generalize to new data. Moreover, commonly-
used statistical methods for microarray data analysis, e.g.,
quality weighting of RNA samples, addition of random
noise to generate technical replicates, and gene set test [16]
have been designed for normally distributed data and it is
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unclear whether we can adapt them to count data. Also the
presence of outliers is an issue that is not well addressed
(addressed in a very ad hoc manner) by existing methods.
To handle that, the authors of [16] take the logarithm of
the raw count of reads and apply normal distribution-based
statistical methods to analyze them. Note that by loga-
rithmic transformation, the dynamic range of the RNA-seq
counts is compressed such that the outlier counts are largely
transformed into “normal” data. As a result, sophisticated
way to detect and discard outliers [18], [19], [20] is not
required.
In this paper, like in [16], [17] we work with log-
transformed gene expression values and propose a unified
statistical model for differential gene expression. Different
from [16], [17], we model sample-specific scaling factors
for between-sample normalization as unknown parameters
and incorporate them into the gene-wise linear models. By
imposing the sparsity-inducing penalty (ℓ1-norm for single
treatment factor and mixed ℓ1/ℓ2-norm for multiple treat-
ment factors) on the regression coefficients and carefully
choosing the penalty parameter, the model is able to achieve
joint accurate detection of DE genes and between-sample
normalization. To fit the model, we first eliminate sample-
specific parameters using optimization argumentation to
formulate the problem as a penalized linear regression
problem, and then solve it with the alternating direction
method of multipliers algorithm (ADMM), which is known
for its fast convergence to modest accuracy [21]. Regarding
the choice of penalty parameter, we theoretically derive
the smallest penalty parameter αmax that leads to all-
zero solution, and thereby find a proper penalty parameter
within [0, αmax]. Simulation studies show that the proposed
methods perform better in terms of detection power and
false-positive rate than existing methods when more than
50% of the genes are differentially expressed and/or the fold
change distribution is asymmetric 1. Moreover, it is robust
against deviations of the distribution of RNA-seq count
data and suffers almost no performance degradation even
when the data is generated according to the probabilistic
assumptions of the previous methods.
Note that our work is preceded by [22] which address the
differential expression problem in a similar way. The differ-
ence is that the model of [22] considers only categorical or
qualitative predictor/explanatory variables (treatment con-
ditions). For example, label “0” is assigned to samples from
the control group and label “1” to samples from the treat-
ment group. While in our model, the precitor/explanatory
variables can take arbitrary numeric values, and is thus a
generalization of [22] from discrete to continuous predictor-
variable model case. Note that the algorithm in [22] does
not apply to the current numeric variable model at hand,
because (i) applicability: it requires that multiple samples
are present in each group but in the continuous-predictor
model the concept of “group” no longer exists, or more
precisely, each group is formed by only one sample; (ii) algo-
rithmic complexity: it requires an p-dimensional exhaustive
search, where p is the number of treatment conditions. When
p > 1 (see Section 4), the algorithm is computationally very
1. Here by “asymmetric” we mean the up- and down-regulated DE
genes are unbalanced in number [(or amount)].
expensive.
The remainder of the paper is organized as follows.
In Section 2, we formulate the problem in the context of
a single treatment factor. In Section 3, we formulate the
problem as a penalized simple regression problem and
derive efficient ADMM algorithm to solve it, together with
the estimation of noise variance and penalty parameter.
In Section 4, we extend the simple regression model to
multiple linear regression model. Comparison with existing
methods is presented in Section 5, followed by discussions
in Section 6.
2 DATA MODEL AND PROBLEM FORMULATION
Throughout the paper, the subscript is used to index the
vectors for rows of a matrix. For example, the i-th row vector
of a matrixA is denoted as ai.
2.1 Data model
Suppose there are a total ofm genes measured in n samples.
Let yij , i = 1,2, . . . ,m, j = 1,2, . . . , n, be the log-transformed
gene expression measurements (a small positive number is
usually added before taking logarithm) for the i-th gene
from the j-th sample. The following statistical model is
assumed
yij ∼ N (β0i + βixj + dj , σ2i ) (2)
where β0i is the y-intercept for gene i, xj , j = 1,2, . . . , n, is
the predictor variable that represents the treatment condi-
tion (e.g., drug dosage) for sample j, βi is the slope or re-
gression coefficient representing log-fold-change of expres-
sion levels of gene i with unit change of xj , dj is the scaling
factor (e.g., log(sequencing depth) or log(library size)) for
sample j for between-sample normalization [6], and σi is
the standard deviation of log-transformed expression levels
of gene i.
In (2), we consider a single treatment condition. Exten-
sion to models with multiple treatment conditions will be
discussed in Section 4.
Our main interest is to detect differentially expressed
(DE) genes, i.e., whether βi is equal to zero. If βi ≠ 0 gene i
is differentially expressed across the n samples; otherwise it
is not.
Remark 2.1. Since β0i and dj in (2) respectively model gene-
specific factor (e.g., gene length) and sample-specific factor,
model (2) able to work with any log-transformed gene
expression measures in the form of
yij = log
cij
li ⋅ qj
, (3)
where cij is the raw counts, li is the length of gene i and qj
is the normalization factor of the j-th sample, since li and
qj can be absorbed into β0i and di, respectively. Note that
gene expressionmeasures of form cij/(li⋅qj) include the raw
counts (with li = qj = 1), measures based on between-sample
normalization only (li = 1) [6], and FPKM and TPM which
are shown in (1) and involve both between- and within-
sample normalization.
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2.2 Penalized likelihood
Since the gene expression measurements yij are indepen-
dent across the genes and samples, the likelihood is given
by
Pr (y∣β
0
,β,d) = m∏
i=1
n
∏
j=1
1√
2πσ2i
exp{−(yij − β0i − βixj − dj)2
2σ2i
} ,
(4)
where
β =
⎛⎜⎜⎜⎝
β1
β2
⋮
βm
⎞⎟⎟⎟⎠
.
Assume that {σ2i }mi=1 are known, maximization of (4) is
equivalent to minimizing the negative log-likelihood:
l (β
0
,β,d;y) = m∑
i=1
n
∑
j=1
1
2σ2i
(yij − β0i − βixj − dj)2 , (5)
where we have ignored the irrelevant constant.
In practice, we solve for {σ2i }mi=1 using an ad hoc ap-
proach, which will be described in Section 3.4.
We introduce a ℓ1-penalty on the βi’s:
p(β) = α ∥β∥
1
∶= α
m
∑
i=1
∣βi∣ . (6)
It is well known that the ℓ1-norm penalty favors sparse
solutions (forces some coefficients to be exactly zero) [23].
This is reasonable since in practice many genes are not
differentially expressed.
The objective function to be minimized is
f (β
0
,β,d) = m∑
i=1
n
∑
j=1
1
2σ2i
(yij − β0i − xjβi − dj)2 + αm∑
i=1
∣βi∣ .
(7)
3 ALGORITHM DEVELOPMENT
3.1 Formulation of (7) as Penalized Simple Linear Re-
gression Model
It can be proved that the optimization problem in (7) is
jointly convex in (β
0
,β,d). Therefore, the minimizer of (7)
is the stationary point.
The derivative of f (β0,β,d) with respect to dj , j =
1,2, . . . , n, is
∂f
∂dj
=
m
∑
i=1
−
1
σ2i
(yij − β0i − xjβi − dj) = 0. (8)
Setting (8) to zero gives
dj =
1
m
∑
i=1
1
σ2i
m
∑
i=1
1
σ2i
(yij − β0i − xjβi) . (9)
Model (2) is non-identifiable because we can simply add
any constant to all the dj ’s and subtract the same constant
from all the β0i’s, while having the same fit. To resolve this
issue, we fix d1 = 0. Therefore
dj = dj − d1 = (y¯(w)⋅j − y¯(w)⋅1 ) − (xj − x1) β¯(w), (10)
where
y¯
(w)
⋅j ∶=
1
m
∑
i=1
1
σ2
i
m
∑
i=1
1
σ2i
yij , for j = 1,2, . . . , n, (11)
β¯
(w)
∶=
1
m
∑
i=1
1
σ2i
m
∑
i=1
1
σ2
i
βi. (12)
On the other hand, from
∂f
∂β0i
= −
1
σ2i
n
∑
j=1
(yij − β0i − xjβi − dj) = 0, (13)
we have
β0i =
1
n
n
∑
j=1
(yij − xjβi − dj) = y¯i⋅ − x¯βi − 1
n
n
∑
j=1
dj . (14)
where
y¯i⋅ ∶=
1
n
n
∑
j=1
yij , for i = 1,2, . . . ,m. (15)
x¯ ∶=
1
n
n
∑
j=1
xj . (16)
From (10) we have
1
n
n
∑
j=1
dj = (y¯(w) − y¯(w)⋅1 ) − (x¯ − x1) β¯(w), (17)
where
y¯
(w)
∶=
1
m
∑
i=1
1
σ2i
m
∑
i=1
1
σ2i
⋅
1
n
n
∑
j=1
yij . (18)
Substituting (17) into (14) yields
β0i = y¯i⋅ + y¯
(w)
⋅1 − y¯
(w)
+ (x¯ − x1) β¯(w) − x¯βi. (19)
Without loss of generality, we make the following as-
sumptions:
Assumption 3.1.
n
∑
j=1
xj = nx¯ = 0,
n
∑
j=1
x
2
j = 1. (20)
This assumption is reasonable since in the model (2) the
center and scaling factor of xj ’s can be absorbed into β0i
and βi, respectively.
Then (19) simplifies to
β0i = y¯i⋅ + y¯
(w)
⋅1 − y¯
(w)
− x1β¯
(w)
. (21)
The sum of (10) and (21) yields
β0i + dj = y¯i⋅ + y¯
(w)
⋅j − y¯
(w)
− xj β¯
(w)
. (22)
Substituting (22) into (7), the latter simplifies to
f (β) = m∑
i=1
1
2σ2i
n
∑
j=1
(y˜ij − xjβi + xj β¯(w))2 + αm∑
i=1
∣βi∣ , (23)
where
y˜ij ∶= yij − y¯i⋅ − y¯
(w)
⋅j + y¯
(w)
. (24)
It can be shown by straightforward calculation that {y˜ij}
satisfies
m
∑
i=1
1
σ2
i
y˜ij = 0. (25)
n
∑
j=1
y˜ij = 0. (26)
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3.2 Model Fitting by ADMM
We propose to use the alternating direction method of
multipliers (ADMM) [21] to solve (23). Although ADMM
can be very slow to converge to high accuracy, it is often the
case that ADMM converges to modest accuracy very fast
(within a few tens of iterations) [21].
To apply the ADMM, the problem (23) is reformulated
as
f (β) = m∑
i=1
1
2σ2i
n
∑
j=1
(y˜ij − xjβi + xjδ0)2 +αm∑
i=1
∣βi∣ , (27a)
subject to
1
m
∑
i=1
1
σ2i
m
∑
i=1
1
σ2
i
βi = δ0. (27b)
The augmented Lagrangian of (27) is (28) at the bottom
of the page.
Step 1: Update βi, i = 1,2, . . . ,m:
The derivative of (28) with respect to βi is
∂Lρ
∂βi
=
1
σ2i
n
∑
j=1
− xj (y˜ij − xjβi + xjδ0) + α∂ ∣βi∣
+
1
m
∑
ℓ=1
1
σ2
ℓ
1
σ2
i
λ + ρ
1
m
∑
ℓ=1
1
σ2
ℓ
1
σ2
i
⎛⎜⎜⎜⎜⎝
1
m
∑
ℓ=1
1
σ2
ℓ
m
∑
ℓ=1
1
σ2
ℓ
βℓ − δ0
⎞⎟⎟⎟⎟⎠
,
(29)
where ∂ ∣βi∣ is the subgradient of ∣βi∣ with respect to βi and
is defined as
∂ ∣βi∣ =
⎧⎪⎪⎪⎪⎨⎪⎪⎪⎪⎩
1, βi > 0
−1, βi < 0[−1,1], βi = 0
Setting (29) equal to zero gives (30) at the bottom of the
page, where T is the soft-thresholding operator:
Tσ2
i
α [x] ∶= sign(x) (∣x∣ − σ2i α)+ =
⎧⎪⎪⎪⎪⎨⎪⎪⎪⎪⎩
x − σ2i α, x > σ
2
i α
x + σ2i α, x < −σ
2
i α
0, −σ2i α ≤ x ≤ σ
2
i α
Step 2: Update δ0:
The derivative of (28) with respect to δ0 is
Lρ (β, δ0, λ) =m∑
i=1
1
σ2
i
n
∑
j=1
xj (y˜ij − xjβi + xjδ0)
− λ + ρ
⎛⎜⎜⎜⎜⎝
δ0 −
1
m
∑
i=1
1
σ2
i
m
∑
i=1
1
σ2i
βi
⎞⎟⎟⎟⎟⎠
.
(31)
Setting (31) equal to zero gives
δ0 =
1
m
∑
i=1
1
σ2i
+ ρ
⎛⎝λ −
m
∑
i=1
1
σ2i
n
∑
j=1
xj y˜ij
⎞⎠ + 1m
∑
i=1
1
σ2i
m
∑
i=1
1
σ2i
βi
=
1
m
∑
i=1
1
σ2i
+ ρ
λ +
1
m
∑
i=1
1
σ2i
m
∑
i=1
1
σ2i
βi,
(32)
where the second equality is due to (25).
Step 3: Update λ:
λ
new = λold + ρ
⎛⎜⎜⎜⎜⎝
1
m
∑
i=1
1
σ2i
m
∑
i=1
1
σ2i
βi − δ0
⎞⎟⎟⎟⎟⎠
(33)
The model fitting algorithm is described in Algorithm 1.
3.3 Estimation of Penalty Parameter α
The (23) can be expressed in matrix form as
f (β) = 1
2
∥Σ1/2 (Ỹ −MβxT)∥2
F
+ α ∥β∥
1
, (40)
where
Σ = diag{σ}, (41)
with
σ = ( 1/σ21 1/σ22 ⋯ 1/σ2m )T , (42)
and
M =
⎛⎜⎜⎜⎝
1 0 ⋯ 0
0 1 ⋯ 0
0 0 ⋱ 0
0 0 ⋯ 1
⎞⎟⎟⎟⎠
−
1
m
∑
i=1
1
σ2i
⎛⎜⎜⎜⎝
1/σ21 1/σ22 ⋯ 1/σ2m
1/σ21 1/σ22 ⋯ 1/σ2m
⋮ ⋮ ⋱ ⋮
1/σ21 1/σ22 ⋯ 1/σ2m
⎞⎟⎟⎟⎠
= Im −
1
m
∑
i=1
1
σ2i
1mσ
T
.
(43)
After expansion, (40) becomes
f (β) = 1
2
∥Σ1/2Ỹ ∥2
F
−β
T
M
T
ΣỸ x+
1
2
β
T
M
T
ΣMβ+α ∥β∥
1
,
(44)
where we exploit the assumption xTx = 1.
Since 1
2
βTMTΣMβ ≥ 0 with equality occurring at β =
0, it is shown that βˆ = 0 is the minimizer of f (β) when
α ≥ ∥MTΣỸ x∥
∞
∶= max
1≤i≤m
∣miTΣỸ x∣ , (45)
wheremi denotes the i-th column ofM in (43).
Note that
M
T
ΣỸ =
⎛⎜⎜⎜⎜⎝
Im −
1
m
∑
i=1
1
σ2i
σ1
T
m
⎞⎟⎟⎟⎟⎠
ΣỸ =ΣỸ , (46)
where the last equality holds because 1TmΣỸ = 0 due to
(25).
Substituting (46) into (45) yields
αmax = ∥ΣỸ x∥∞ =maxj ∣ 1σ2i x
T
y˜i∣ . (47)
Our strategy is to set α = ǫαmax, where 0 < ǫ < 1.
Empirically we found that ǫ ∈ [0.001,0.1] works well in
a wide range of parameter settings. We set ǫ = 0.01 in
Section 5.
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Algorithm 1 Alternating direction method of multipliers
Input: Log-transformed gene expression measurements: {{yij}mi=1}nj=1, predictor variables: {xj}nj=1 and estimated noise
variance: {σ2i }mi=1.
1: Transform data. Normalize {xj}nj=1 to zero mean and unit norm:
x˜j ← xj − x¯¿ÁÁÀ n∑
j=1
(xj − x¯)2
, with x¯ ∶=
1
n
n
∑
j=1
xj .
Center yij to zero mean over row index i and column index j: calculate y˜ij according to (24).
2: Initialization: Set ρ > 0 to any fixed constant, e.g., ρ = 1 [21]; choose the penalty parameter α according to Section 3.3.
3: k = 0; randomly initialize β = β0i , i = 1,2, . . . ,m, δ0 = δ
0
0 , and λ = λ
0.
4: repeat
5: Update βi, i = 1,2, . . . ,m
6: for i = 1,2, . . . ,m do
β
k+1
i =
σ2i ( m∑
ℓ=1
σ
−2
ℓ )2
σ2i ( m∑
ℓ=1
σ
−2
ℓ )2 + ρ
Tσ2
i
α
⎡⎢⎢⎢⎢⎢⎢⎢⎢⎣
⎛⎝
n
∑
j=1
x˜j y˜ij + δ
k
0
⎞⎠ − ρm
∑
ℓ=1
1
σ2
ℓ
⎛⎜⎜⎜⎜⎝
1
m
∑
ℓ=1
1
σ2
ℓ
∑
ℓ≠i
1
σ2
ℓ
β
k
ℓ − δ0 +
λk
ρ
⎞⎟⎟⎟⎟⎠
⎤⎥⎥⎥⎥⎥⎥⎥⎥⎦
. (34)
7: end for
8: Update δ0:
δ
k+1
0 =
1
m
∑
i=1
1
σ2i
+ ρ
λ
k
+
1
m
∑
i=1
1
σ2i
m
∑
i=1
1
σ2i
β
k+1
i . (35)
9: Update λ:
λ
k+1 = λk + ρ
⎛⎜⎜⎜⎜⎝
1
m
∑
i=1
1
σ2i
m
∑
i=1
1
σ2i
β
k+1
i − δ
k+1
0
⎞⎟⎟⎟⎟⎠
(36)
10: k ← k + 1;
11: until convergence or maximum number of iterations is reached.
Output: βi = βki , i = 1,2, . . . ,m, β¯
(w) = δk0 , and
β0i = y¯i⋅ + y¯
(w)
⋅1 − y¯
(w)
− x˜1β¯
(w)
, i = 1,2, . . . ,m (37)
d1 = 0, dj = (y¯(w)⋅j − y¯(w)⋅1 ) − (x˜j − x˜1) β¯(w), j = 2, . . . , n (38)
12: Recover the original parameter space:
β
′
0i = β0i −
βix¯¿ÁÁÀ n∑
j=1
(xj − x¯)2
, β
′
i =
βi¿ÁÁÀ n∑
j=1
(xj − x¯)2
, i = 1,2, . . . ,m. (39)
3.4 Estimation of {σ2i }mi=1
To solve for {σ2i }mi=1, consider the negative log-likelihood
function in (4) with {σ2i }mi=1 being unknown parameters as
well:
l =
m
∑
i=1
⎡⎢⎢⎢⎢⎣
n
2
log(2πσ2i ) + 1
2σ2i
n
∑
j=1
(yij − β0i − xjβi − dj)2⎤⎥⎥⎥⎥⎦ .
(48)
Taking partial derivatives of l(⋅) with respect to dj and
β0i and setting the results to zero, we arrive at (10) and (21)
respectively. The sum of (10) and (21) gives (22).
Taking partial derivatives of l(⋅) with respect to βi and
setting the result to zero, we have
βi =
n
∑
j=1
xjyij −
n
∑
j=1
xj (β0i + dj) . (49)
Substituting (22) into (49) yields
βi =
n
∑
j=1
xjyij −
1
m
∑
i=1
1
σ2
i
m
∑
i=1
1
σ2i
n
∑
j=1
xjyij + β¯
(w)
, (50)
where β¯(w) is defined in (12).
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Taking partial derivatives of σ2i and setting the result to
zero gives
σ
2
i =
1
n
n
∑
j=1
(yij − β0i − xjβi − dj)2 . (51)
Substituting (22) into (51) yields
σ
2
i =
1
n
n
∑
j=1
(yij − y¯i⋅ − y¯(w)⋅j + y¯(w) − xjβi + xj β¯(w))2 , (52)
where y¯i⋅, y¯
(w)
⋅j and y¯
(w) are defined in (15), (11) and (18),
respectively.
Given initial estimates for β¯(w) and {σ2i }mi=1, we can al-
ternate equations (50), (52) and (12) iteratively to graduately
refine the estimates for βi and σ
2
i , as shown in Algorithm 2.
Algorithm 2 Estimation of {σ2i }mi=1
Input: Log-transformed gene expression measurements:{{yij}mi=1}nj=1 and predictor variables: {xj}nj=1.
1: Normalize {xj}nj=1 to zero mean and unit norm:
xj ← xj − x¯¿ÁÁÀ n∑
j=1
(xj − x¯)2
, with x¯ ∶=
1
n
n
∑
j=1
xj .
2: Initialization: β¯(w) = 0, σ21 = σ
2
2 = ⋯ = σ
2
m = 1.
3: repeat
4: for i = 1,2, . . . ,m do
Update βi, i = 1,2, . . . ,m according to (50).
5: end for
6: Update {σ2i }mi=1 according to (52).
7: Update β¯(w) according to (12).
8: until convergence or maximum number of iterations is
reached.
Output: σˆ2i = σ
2
i , i = 1,2, . . . ,m.
Then we take another weighted average of σˆ2i and the
estimated mean variance across all the genes to obtain a
robust estimate for σ2i . That is
σˆ
′2
i = (1 −w)σˆ2i +wσˆ2 (53)
where
σˆ2 =
1
m
m
∑
i=1
σˆ
2
i , (54)
and the weight w is calculated using the following formula
as suggested in [24] which is based on an empirical Bayes
approach
w =
2(m − 1)
n + 1
⎛⎜⎜⎝
1
m
+
(σˆ2)2
∑mi=1 (σˆ2i − σˆ2)2
⎞⎟⎟⎠ . (55)
This kind of variance estimation approach is widely used
in differential gene expression analysis with small sample
sizes [25], [26]. The estimated variances σˆ′2i , i = 1,2, . . . ,m,
can then be used in Algorithm 1 to solve for {βi}mi=1.
Remark 3.1. In the special case of σ21 = σ
2
2 = ⋯ = σ
2
m = σ
2, it
no longer requires to estimate σ2 since the unknown σ2 in
(7) can be absorbed into the penalty parameter α.
4 EXTENSION TO MULTIPLE LINEAR REGRESSION
MODEL AND ALGORITHM DEVELOPMENT
In the multiple linear regression model, each response or
outcome is modeled by p > 1 predictors:
yij ∼ N (β0i +βTi xj + dj , σ2i ) (56)
where
βi =
⎛⎜⎜⎜⎝
βi1
βi2
⋮
βip
⎞⎟⎟⎟⎠
∈ Rp×1 (57)
is a vector of regression coefficients representing log-fold-
change of expression levels of gene i between treatment
conditions, and
xj =
⎛⎜⎜⎜⎝
xj1
xj2
⋮
xjp
⎞⎟⎟⎟⎠
∈ Rp×1 (58)
is a vector of independent/explanatory variables represent-
ing the treatment conditions (drug dosage, blood pressure,
age, BMI, etc.) for sample j, and β0i, dj , and σi respectively
represent the y-intercept of gene i, scaling factor for sample
j and standard deviation of log-transformed expression
levels of gene i, as defined in the simple regression model.
Since the sample values are independent across the
genes and samples, the likelihood is given by
Pr (y∣β
0
,{βi},d) = m∏
i=1
n
∏
j=1
1√
2πσ2i
exp
⎧⎪⎪⎪⎨⎪⎪⎪⎩−
(yij − β0i −βTi xj − dj)2
2σ2
i
⎫⎪⎪⎪⎬⎪⎪⎪⎭ .
(59)
Assume that {σ2i }mi=1 are known, maximization of (59)
leads to minimizing the negative log-likelihood:
l (β
0
,{βi},d;y) = m∑
i=1
n
∑
j=1
1
2σ2i
(yij − β0i −βTi xj − dj)2 (60)
The objective function to be minimized is
f (β
0
,{βi},d) = m∑
i=1
n
∑
j=1
1
2σ2i
(yij − β0i −xTj βi − dj)2+m∑
i=1
p (βi) .
(61)
Below we introduce two types of penalty function p (βi).
1) Type I penalty:
p (βi) = α ∣βip∣ . (62)
Gene i is differentially expressed if βip ≠ 0 and not
otherwise. This penalty is for the applications where
one covariate is of main interest (e.g., treatment)
while we want to adjust for all possible effects of
other confounding covariates (e.g., age, gender, etc).
2) Type II penalty:
p (βi) = α ∥βi∥ . (63)
Gene i is differentially expressed if βi ≠ 0 and not
otherwise. This penalty is for the applications where
all covariates are of interest and we want to identify
the genes for which at least one covariate has an
effect.
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It can be proved that the optimization problem (61) with
penalty (62) or (63) is jointly convex in (β0,{βi},d).
Assume that
n
∑
j=1
xj = 0, (64)
and set d1 = 0. Using similar argumentation as in Section 3.1
to eliminate β
0
and d, we simplify (61) to
f ({βi}) = m∑
i=1
1
2σ2
i
n
∑
j=1
(y˜ij −xTj βi +xTj β¯(w))2 + m∑
i=1
p (βi) ,
(65)
where y˜ij is the same as that in (24), and
β¯
(w)
∶=
1
m
∑
i=1
1
σ2
i
m
∑
i=1
1
σ2i
βi. (66)
4.1 Regression with Type I Penalty: Model Fitting by
ADMM
To apply the ADMM, we reformulate the Type I penalized
regression problem as
f ({βi},δ0) = m∑
i=1
1
2σ2
i
n
∑
j=1
(y˜ij −xTj βi +xTj δ0)2 + αm∑
i=1
∣βip∣ ,
(67a)
subject to
1
m
∑
i=1
1
σ2i
m
∑
i=1
1
σ2i
βi = δ0. (67b)
The augmented Lagrangian of (67) is (65) at the bottom
of the page.
Step 1: Update βi, i = 1,2, . . . ,m:
Taking partial derivative of (65) with respect to βi and
setting the result to zero gives⎡⎢⎢⎢⎢⎢⎢⎢⎢⎢⎣
1
σ2i
X
T
X +
ρ
σ4i
1
( m∑
ℓ=1
1
σ2
ℓ
)2
Ip
⎤⎥⎥⎥⎥⎥⎥⎥⎥⎥⎦
βi +α
⎛⎜⎜⎜⎝
0
⋮
0
∂ ∣βip∣
⎞⎟⎟⎟⎠
= vi. (69)
where
X =
⎛⎜⎜⎜⎜⎝
xT1
xT2
⋮
xTn
⎞⎟⎟⎟⎟⎠
=
⎛⎜⎜⎜⎝
x11 x12 ⋯ x1p
x21 x22 ⋯ x2p
⋮ ⋮ ⋱ ⋮
xn1 xn2 ⋯ xnp
⎞⎟⎟⎟⎠
∈ Rn×p, (70)
∂ ∣βip∣ is the subgradient of ∣βip∣ with respect to βip, and
vi =
1
σ2i
⎛⎝
n
∑
j=1
xj y˜ij +X
T
Xδ0
⎞⎠
−
ρ
σ2i
1
m
∑
ℓ=1
1
σ2
ℓ
⎛⎜⎜⎜⎜⎝
1
m
∑
ℓ=1
1
σ2
ℓ
∑
ℓ≠i
1
σ2
ℓ
βℓ − δ0 +
λ
ρ
⎞⎟⎟⎟⎟⎠
,
(71)
Using the block matrix representation:
1
σ2i
X
T
X +
ρ
σ4i
1
( m∑
ℓ=1
1
σ2
ℓ
)2
Ip =Q = ( Q̃ q
qT qpp
) ,
βi = ( β−iβip ) , vi = ( v
−
i
vip
) ,
where Q̃ is the submatrix ofQwith last row and last column
deleted, from (69) we have
Q̃β
−
i + qβip = v
−
i (72)
q
T
β
−
i + qppβip + α∂ ∣βip∣ = vip. (73)
From (72) it follows
β
−
i = Q̃
−1 (v−i − qβip) . (74)
Substituting (74) into (73) yields
βip =
1
qpp − qTQ̃
−1
q
Tα [vip − qTQ̃−1v−i ] . (75)
Step 2: Update δ0:
Taking the derivative of (65) with respect to δ0 and
setting the result to zero gives
δ0 = (m∑
i=1
1
σ2i
X
T
X + ρIp)−1 λ + 1m
∑
i=1
1
σ2i
m
∑
i=1
1
σ2i
βi, (76)
where we have exploited (25).
Step 3: Update λ:
λ
new = λold + ρ
⎛⎜⎜⎜⎜⎝
1
m
∑
i=1
1
σ2i
m
∑
i=1
1
σ2i
βi − δ0
⎞⎟⎟⎟⎟⎠ . (77)
4.2 Regression with Type II Penalty: Model Fitting by
ADMM
The Type II penalized regression problem is reformulated as
f ({βi},δ0) = m∑
i=1
1
2σ2i
n
∑
j=1
(y˜ij −xTj βi +xTj δ0)2 + αm∑
i=1
∥βi∥ ,
(78a)
subject to
1
m
∑
i=1
1
σ2
i
m
∑
i=1
1
σ2i
βi = δ0. (78b)
The augmented Lagrangian of (78) is (76) at the bottom
of the page.
Step 1: Update βi, i = 1,2, . . . ,m:
The relevant terms to compute the derivatives of (76)
with respect to βi is (77) at the bottom of the page, where c
is an irrelevant constant which does not depend on βi, and
vi is defined in (71).
It can be shownwhen ∥vi∥ ≤ α thenβi = 0; otherwise de-
note the eigendecomposition of XTX as XTX = UDUT,
we have that minimization of (77) is equivalent to
min
β
i
1
2
∥Zβi − bi∥2 + α ∥βi∥ . (81a)
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where
Z =
⎡⎢⎢⎢⎢⎢⎢⎢⎢⎢⎣
1
σ2i
D +
ρ
σ4i
1
( m∑
ℓ=1
1
σ2
ℓ
)2 Ip
⎤⎥⎥⎥⎥⎥⎥⎥⎥⎥⎦
1/2
U
T
, (81b)
bi =
⎡⎢⎢⎢⎢⎢⎢⎢⎢⎢⎣
1
σ2i
D +
ρ
σ4i
1
( m∑
ℓ=1
1
σ2
ℓ
)2 Ip
⎤⎥⎥⎥⎥⎥⎥⎥⎥⎥⎦
−1/2
U
T
vi. (81c)
As in [27], we use a coordinate descent procedure to
optimize (81). For each s, given the estimate of {βˆiℓ}ℓ≠s, βis
can be estimated by solving
min
βis
1
2
∥zsβis − r(s)i ∥2 + α√β2is +∑
ℓ≠s
βˆ
2
iℓ, (82)
where
r
(s)
i = bi −∑
ℓ≠s
zℓβiℓ. (83)
We solve (82) via a one-dimensional search. Note that the
solution to (82) falls between 0 and βoiℓ = z
T
s r
(s)
i / ∥zs∥2, the
ordinary least-squares estimate. We can the optimize func-
tion in the R package, or fminbnd function in MATLAB,
which perform one-dimensional search based on golden
section search and successive parabolic interpolation.
After updating {βi}mi=1, the updates of δ0 and λ turn out
to be the same as that in Section 4.1.
4.3 Estimation of Penalty Parameter α
The (65) can be expressed in matrix form as
f (B) = 1
2
∥Σ1/2 (Ỹ −MBXT)∥2
F
+ p (B) , (84)
where M and X are respectively defined in (43) and (70),
and
B =
⎛⎜⎜⎜⎜⎝
βT
1
βT2
⋮
βTm
⎞⎟⎟⎟⎟⎠ =
⎛⎜⎜⎜⎝
β11 β12 ⋯ β1p
β21 β22 ⋯ β2p
⋮ ⋮ ⋱ ⋮
βm1 βm2 ⋯ βmp
⎞⎟⎟⎟⎠ ∈ R
m×p
, (85)
and p (B) is the penalty function.
The derivative of f (B) with respect to B is
∂f
∂B
=MTΣMBXTX −MTΣỸ X +
∂p (B)
∂B
. (86)
4.3.1 Type I Penalty
When p (B) = αm∑
i=1
∣βip∣, its derivative with respect to B is
∂p (B)
∂B
= α
⎛⎜⎜⎜⎝
0 ⋯ 0 ∂ ∣β1p∣
0 ⋯ 0 ∂ ∣β2p∣
⋮ ⋱ ⋮ ⋮
0 ⋯ 0 ∂ ∣βmp∣
⎞⎟⎟⎟⎠ = ( 0m×(p−1) α
∂∥βp∥
1
∂β
p ) .
(87)
Denote
X = ( x1 ⋯ xp−1 xp ) = ( X1 xp ) ,
B = ( β1 ⋯ βp−1 βp ) = ( B1 βp ) .
Setting (86) equal to zero gives
M
T
ΣM (B1XT1 +βpxpT)X1 =MTΣỸ X1 (88)
M
T
ΣM (B1XT1 +βpxpT)xp + α∂ ∥βp∥1
∂βp
=MTΣỸ xp.
(89)
Since MTΣM is rank deficient2, the solution to (88)
is not unique. We apply the pseudoinverse of MTΣM to
obtain the minimum-norm solution to (88):
B1 = (MTΣM)† (MTΣỸ −MTΣMβpxpT)X1 (XT1X1)−1 .
(90)
Substituting (90) into (89) yields
M
T
ΣMβ
p
x
pT [In −X1 (XT1X1)−1XT1 ]xp + α∂ ∥βp∥1
∂βp
=MTΣỸ [In −X1 (XT1X1)−1XT1 ]xp.
(91)
Note that to arrive at (91), we have exploited the fact that(MTΣM)(MTΣM)†MTΣ =MTΣwhich is due to that
MTΣM =MTΣ according to the definition of M in (43)
and the definition of the pseudoinverse of a matrix.
Since the coefficient matrix of βp, i.e., MTΣM ⋅(xpT [In −X1 (XT1X1)−1XT1 ]xp) is positive semidefi-
nite, (91) implies that when
α ≥ ∥MTΣỸ [In −X1 (XT1X1)−1XT1 ]xp∥
∞
= ∥ΣỸ [In −X1 (XT1X1)−1XT1 ]xp∥
∞
=max
j
∣ 1
σ2i
y˜i
T [In −X1 (XT1X1)−1XT1 ]xp∣ ,
(92)
where the next to last equality is due to (46), we obtain zero
solution.
4.3.2 Type II Penalty
The derivative of p (B) = αm∑
i=1
∥βi∥ with respect to B is
∂p (B)
∂B
= α
⎛⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
∂∥β
1
∥
∂β
T
1
∂∥β
2
∥
∂β
T
2
⋮
∂∥β
m
∥
∂β
T
m
⎞⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
, (93)
where
∂∥β
i
∥
∂β
i
= βi∥β
i
∥ if βi ≠ 0 and ∥∂∥βi∥∂βi ∥ ≤ 1 other-
wise [27], [28].
Setting (86) equal to zero yields
X
T
XB
T
M
T
Σm
i
−X
T
Ỹ
T
Σm
i
+ α
∂ ∥βi∥
∂βi
= 0p×1, (94)
for i = 1,2, . . . ,m, wheremi is the i-th column ofM in (43).
The minimizer to f (B) is a zero matrix when
α ≥max
j
∥XTỸ TΣmi∥ . (95)
2. Simple calculation shows that the rank of MTΣM is m − 1.
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Note that
Ỹ
T
Σm
i = Ỹ
T
Σ
⎛⎜⎜⎜⎜⎝ei −
1
m
∑
ℓ=1
1
σ2
ℓ
1
σ2i
1m
⎞⎟⎟⎟⎟⎠ = Ỹ
T
Σei =
1
σ2i
y˜i,
(96)
where the next to last equality is due to (25).
Substituting (96) into (95) yields
αmax =max
j
∥ 1
σ2i
X
T
y˜i∥ . (97)
4.4 Estimation of {σ2i }mi=1
To solve for {σ2i }mi=1, consider the negative log-likelihood
function with {σ2i }mi=1 being unknown parameters as well:
l (β
0
,{βi},d;y) = m∑
i=1
⎡⎢⎢⎢⎢⎣n2 log(2πσ2i ) + 12σ2i
n
∑
j=1
(yij − β0i −xTj βi − dj)2⎤⎥⎥⎥⎥⎦ .
(98)
Taking partial derivatives of l(⋅) with respect to dj and
β0i and setting the result to zero, we arrive at
dj = dj − d1 = (y¯(w)⋅j − y¯(w)⋅1 ) − (xj −x1)T β¯(w), (99)
β0i = y¯i⋅ −
1
n
n
∑
j=1
x
T
j βi −
1
n
n
∑
j=1
dj = y¯i⋅ + y¯
(w)
⋅1 − y¯
(w)
−x
T
1 β¯
(w)
.
(100)
where to derive the second equality we have exploited
assumption (64).
The sum of (99) and (100) gives
β0i + dj = y¯i⋅ + y¯
(w)
⋅j − y¯
(w)
−x
T
j β¯
(w)
. (101)
Taking partial derivatives of l(⋅) with respect to βi and
setting the result to zero, we have
βi =
n
∑
j=1
xjyij −
n
∑
j=1
xj (β0i + dj) . (102)
Substituting (101) into (102) yields
βi = (XTX)−1
⎡⎢⎢⎢⎢⎢⎢⎢⎢⎣
n
∑
j=1
xjyij −
1
m
∑
i=1
1
σ2i
m
∑
i=1
1
σ2
i
n
∑
j=1
xjyij
⎤⎥⎥⎥⎥⎥⎥⎥⎥⎦
+ β¯
(w)
,
(103)
where β¯
(w)
is defined in (66).
Taking partial derivatives of σ2i and setting the result to
zero gives
σ
2
i =
1
n
n
∑
j=1
(yij − β0i −xTj βi − dj)2 . (104)
Substituting (101) into (104) yields
σ
2
i =
1
n
n
∑
j=1
(yij − y¯i⋅ − y¯(w)⋅j + y¯(w) −xTj βi +xTj β¯(w))2 ,
(105)
where y¯i⋅, y¯
(w)
⋅j and y¯
(w) are defined in (15), (11) and (18),
respectively.
Given initial estimates for β¯
(w)
and {σ2i }mi=1, estimates
for βi and σ
2
i can then be iteratively updated using equa-
tions (103), (105), and (66) until convergence.
After estimating σ2i ’s, they can then be shrinked
(squeezed) toward the common noise variance to obtain
robust estimates for σ2i , as done in Section 3.4.
5 EXPERIMENTS
We evaluate the performance of the proposed algorithms.
To save space, we only verify the proposed algorithm for
the simple regression model (2) (referred to as slr-ADMM).
We set the penalty parameter as α = 0.01αmax, where αmax
is determined according to (47).
5.1 Simple Test with Synthetic Data
We simulate RNA-seq data with a total of m = 1000 genes
and n = 15 samples. Other parameters are set as below.
Table 1
Nonlinear Model Results
parameter meaning
β0i ∼ N(−3,2) y-intercept
βi = 0 log-fold change for non-DE genes
βi ∼ N(2,1) log-fold change for up-regulated DE genes
βi ∼ N(−2,1) log-fold change for down-regulated DE genes
xj ∼ N(0,1) condition data
yij ∼ N(β0i + βixj ,0.1) log gene expression
log(li) ∼ unif(5,10) log gene lengths
Nj ∼ Unif(3,5) × 107 library sizes
cij = ⌊Nj ⋅ lie
yij m
i=1
∑
m
i=1
lie
yij
⌋ + 1 read counts
We first simulate with 700 non-DE genes and 300 DE
genes. Among DE genes 50% are up-regulated while the
remaining 50% are down-regulated. The fitted {βi}mi=1 us-
ing slr-ADMM are plotted in Figure 1(a). We see that the
non-DE genes corresponds to exactly zero or close-to-zero
coefficients while DE genes corresponds to large non-zero
coefficients and they are easily distinguishable from each
other. In Figure 1(b), we increase the percent of up-regulated
DE genes to 70%. Our method still retrieves almost all
non-zero βi’s while shrinking all other βi’s to zero. We
further increase the percent of up-regulated DE genes to
90%, for which our method still achieves accurate estimates
[Figure 1(c)].
In Figure 1(d-f), we increase the number of DE genes
to 500, among which 50%, 70% or 90% are up-regulated
while others are down-regulated. Our method still achieves
accurate estimates. In Figure 1(g-h), we further increase the
number of DE genes to 700 among which 50% or 70% are
up-regulated, for which our method still achieves accurate
estimates when. Only when we simulate with 700 DE genes
among which 90% are up-regulated, our method fails to
distinguish between DE and non-DE genes since the esti-
mated regression coefficients of the latter are not zero either
[Figure 1(i)]
Using a different gene expression measure such as CPM,
RPKM or TPM values computed with formulas in (1) yields
essentially the same result.
5.2 Comparison with Existing Methods with Real Data
We compare our method with edgeR-robust [20], [29], DE-
Seq2 [18], and voom [16], [17], all of which are state-of-the-
art methods for detecting differential gene expression from
RNA-seq data.
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(i) 700 DE genes, among which 90% are up-regulated
Figure 1. Estimated βi from simulated data with simple linear regression
model. The number of genes is m = 1000 and number of samples is
n = 15. The penalty parameter is set as α = 0.01αmax, where αmax is
determined according to (47).
We use RNA-seq data with a total of m = 1000 genes
and n = 15 samples. We simulate both log-normally dis-
tributed read counts, which is the model assumptions of
voom and slr-ADMM, as well as negative-binomially dis-
tributed read counts, which is the underlying assumption of
edgeR-robust and DESeq2. The gene expression levels and
library sizes for both simulations are generated based on a
real RNA-seq dataset [30]. The read counts are simulated
according to[ [20]]. We slightly modify the simulator to
allow log-normally distributed data, as well as variable
fold changes. We simulate data sets with 30%, 50%, 70%,
or 90% DE genes, among which 50%, 70% or 90% are up-
regulated while others are down-regulated. The log-fold
changes for unit changes of explanatory variables, i.e., βi’s,
for up-regulated DE genes are assumed to be distributed as
N (1,1), while that for down-regulated DE genes are dis-
tributed as N (−1,1). We consider high signal-to-noise ratio
(low noise level) scenarios 3, and set the negative-binomial
dispersion parameter to one fifth of that generated from the
real RNA-seq dataset. For log-normal data simulation, log
read counts are assumed to be normally distributed with
σ = 0.1.
The AUCs for DE gene detection from log-normally and
negative-binomially distributed data using all four methods
are summarized in Tables 2 and 3, respectively.
In Table 2, we see that the voom and slr-ADMM perform
the best with log-normally distributed data. In relatively
easier cases where only a small proportion of genes are dif-
ferentially expressed, in a symmetric manner (which means
the numbers of up- and down-regulated genes among DE
genes are roughly the same), the voom and DESeq2 perform
the best. The slr-ADMM is slightly inferior to the best
performer but by only a small margin (i.e., within approx-
imately one standard error for the log-normal distributed
datasets). In challenging cases where a large proportion of
genes are differentially expressed in a asymmetric manner
(e.g., when more than 75% genes are up-regulated), the slr-
ADMM performs the best. And with the increase of the
percent of DE genes and/or percent of up-regulated genes,
the performance gain of the slr-ADMM over completing
methods increases and becomes more significant.
For negative-binomially distributed data, in Table 3 we
see that the edgeR-robust and DESeq2 perform the best
in easy cases. But again, in challenging scenarios where a
large proportion of genes are differentially expressed in a
asymmetric manner, the slr-ADMM is superior to all other
methods.
Note that when more samples are available (e.g., n = 25),
the performance gain of the slr-ADMM over completing
methods becomes even more significant, for both log-
normally and negative-binomially distributed data. For sake
of conciseness, the results are not shown here.
6 DISCUSSION
A unified statistical model is proposed for joint between-
sample normalization and DE detection of RNA-seq data.
The sample-specific normalization factors are modeled as
3. For low SNRs, the simulation results are essentially similar except
that the relative performance gain or loss becomes less significant and
non-typical, which renders it difficult to interpret.
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Table 2
AUC comparison of edgeR-robust, DESeq2, limma and slr-ADMM in
log-normally distributed data. The number of samples is n = 15. The
table shows the percent of DE genes (DE %), percent of up-regulated
genes among all the DE genes (Up %), as well as the mean AUCs for
all four methods measured using 10 simulated replicates. The standard
errors of the mean AUCs are given in parentheses.
DE (%) Up (%) edgeR-robust DESeq2 voom slr-ADMM
30 50 0.954 0.955 0.962 0.9604
(0.0023) (0.0021) (0.002) (0.0016)
30 70 0.9476 0.9506 0.9585 0.9615
(0.004) (0.0039) (0.004) (0.004)
30 90 0.9298 0.9365 0.9404 0.9554
(0.0054) (0.0029) (0.0043) (0.0018)
50 50 0.9498 0.9516 0.9607 0.9593
(0.0023) (0.0022) (0.0023) (0.0022)
50 70 0.9214 0.9333 0.9357 0.9558
(0.0031) (0.0024) (0.0029) (0.0029)
50 90 0.8661 0.8852 0.8926 0.9499
(0.0066) (0.0045) (0.0055) (0.0013)
70 50 0.9482 0.9498 0.9574 0.9564
(0.0023) (0.0023) (0.0019) (0.0023)
70 70 0.8556 0.8925 0.8818 0.9467
(0.0031) (0.0036) (0.0033) (0.0023)
70 90 0.6936 0.7598 0.7223 0.8587
(0.0083) (0.0074) (0.0074) (0.0074)
Table 3
AUC comparison of edgeR-robust, DESeq2, limma and slr-ADMM in
negative-binomially distributed data. See Table 2 for descriptions.
DE (%) Up (%) edgeR-robust DESeq2 voom slr-ADMM
30 50 0.8935 0.8942 0.8941 0.8909
(0.0051) (0.0046) (0.0042) (0.0042)
30 70 0.892 0.8914 0.8897 0.8915
(0.0038) (0.0046) (0.0043) (0.0045)
30 90 0.8711 0.8707 0.868 0.8875
(0.0047) (0.0034) (0.0046) (0.0038)
50 50 0.9116 0.9119 0.9109 0.9074
(0.0024) (0.0027) (0.0024) (0.0025)
50 70 0.8741 0.8751 0.8702 0.8872
(0.0043) (0.0032) (0.0043) (0.0034)
50 90 0.8096 0.8166 0.8043 0.8695
(0.0052) (0.0035) (0.006) (0.0034)
70 50 0.9039 0.9024 0.9024 0.8992
(0.0023) (0.0019) (0.002) (0.0018)
70 70 0.8493 0.8423 0.8421 0.8742
(0.0044) (0.0054) (0.0047) (0.0028)
70 90 0.661 0.661 0.6535 0.7375
(0.0079) (0.0073) (0.0073) (0.0067)
unknown parameters and jointly estimated together with
DE detection. As a result, the model is robust against
normalization errors and is independent of the units (i.e.,
counts, CPM/RPM, RPKM/FPKM or TPM) in which gene
expression levels are summarized.
For the model with a single treatment condition, we in-
troduce the ℓ1-norm penalty to the linear regression model.
The ℓ1-norm penalty favors sparse solutions (forces some
coefficients to be exactly zero). This is desirable since many
genes are not differentially expressed. From a Bayesian point
of view, the lasso penalty corresponds to a Laplace (dou-
ble exponential, with zero-mean) prior over the regression
coefficients. By contrast, existing methods do not exploit
the sparsity-inducing prior information. For the model with
multiple treatment conditions, two types of penalty func-
tions are introduced. In the first one only one covariate
is of interest while all other covariates are treated as con-
founding factors. We are interested in testing whether that
specific covariate is associated with differential expression.
In the second case all covariates are of interest (there are
no confounding covariates) and we are interested in testing
whether any covariate affects the differential expression
of a gene. Regarding choice of the penalty parameter, we
theoretically derive the maximum penalty parameter αmax
that leads to all-zero solution, and set α = ǫαmax with
0 < ǫ < 1. Empirically we found that the performance is not
sensitive to ǫ and setting ǫ = 0.01works quite well in a wide
range of parameter settings. This avoids computationally
expensive cross validation procedure to tune the penalty
parameter.
Simulation studies show that the proposed methods
perform better than or comparably to existing methods in
terms of AUC. The performance gain is more significant
when a large proportion of genes (e.g., more than half) are
differentially expressed and/or the up- and down-regulated
DE genes are unbalanced in number, particularly in the
presence of high signal-to-noise ratios or large sample-size.
The R as well as MATLAB codes of the algorithms
described in the paper are available for download at
http://www-personal.umich.edu/∼jianghui/lr-ADMM/.
The authors would like to thank...
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